Label: DOC JOHNSON PROLONGING GINSENG- benzocaine cream

  • NDC Code(s): 69503-003-01
  • Packager: Health Devices Corporation
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None

Drug Label Information

Updated August 14, 2023

If you are a consumer or patient please visit this version.

View All Sections
  • SPL UNCLASSIFIED SECTION

    Drug Facts

  • Active Ingredient

    Benzocaine 7.5% w/w

  • Purpose

    Male Genital Desensitizer

  • Use

    • Helps in the prevention of premature ejaculation.
  • Warnings

    For external use only

    When using this product

    • Avoid contact with eyes
    • If you or your partner develop a rash or irritation, such as burning or itching, discontinue use. If symptoms persist, consult a doctor.
    • Premature ejaculation may be due to a condition requiring medical supervision. If this product used as directed, does not provide relief, discontinue use and consult a doctor.

    Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center right away.

  • Directions

    • Apply a small amount to head and shaft of penis 2-3 minutes before intercourse or use as directed by a physician.
    • Wash product off after intercourse.
  • Other Information

    Store at 20-25° C (68-77° F)

  • Inactive Ingredients

    Acrylates/C10-30 Alkyl Acrylate Crosspolymer, Diazolidinyl Urea, Ethoxydiglycol, Ginseng Root Extract, Methylparaben, Propanediol, Propylene Glycol, Propylparaben, Purified Water, Triethanolamine.

  • SPL UNCLASSIFIED SECTION

    Distributed by Doc Johnson Enterprises.
    P.O. Box 9908, North Hollywood, CA 91609-9908

  • PRINCIPAL DISPLAY PANEL - 56 g Tube Carton

    ie
    INTIMATE ENHANCEMENTS

    PROLONGING™
    with ginseng

    MALE GENITAL
    DESENSITIZING
    DELAY CREAM

    maximize performance
    and partner satisfaction

    Net Wt. 2oz. (56g)

    PRINCIPAL DISPLAY PANEL - 56 g Tube Carton
  • INGREDIENTS AND APPEARANCE
    DOC JOHNSON PROLONGING GINSENG 
    benzocaine cream
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:69503-003
    Route of AdministrationTOPICAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    BENZOCAINE (UNII: U3RSY48JW5) (BENZOCAINE - UNII:U3RSY48JW5) BENZOCAINE7.5 g  in 100 g
    Inactive Ingredients
    Ingredient NameStrength
    CARBOMER COPOLYMER TYPE B (ALLYL PENTAERYTHRITOL CROSSLINKED) (UNII: 809Y72KV36) 0.3 g  in 100 g
    DIAZOLIDINYL UREA (UNII: H5RIZ3MPW4) 0.3 g  in 100 g
    DIETHYLENE GLYCOL MONOETHYL ETHER (UNII: A1A1I8X02B) 15 g  in 100 g
    METHYLPARABEN (UNII: A2I8C7HI9T) 0.11 g  in 100 g
    ASIAN GINSENG (UNII: CUQ3A77YXI) 0.1 g  in 100 g
    PROPANEDIOL (UNII: 5965N8W85T) 10 g  in 100 g
    PROPYLENE GLYCOL (UNII: 6DC9Q167V3) 0.56 g  in 100 g
    PROPYLPARABEN (UNII: Z8IX2SC1OH) 0.03 g  in 100 g
    WATER (UNII: 059QF0KO0R) 65.8 g  in 100 g
    TROLAMINE (UNII: 9O3K93S3TK) 0.3 g  in 100 g
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:69503-003-0156 g in 1 TUBE; Type 0: Not a Combination Product05/23/2023
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    OTC monograph drugM01705/23/2023
    Labeler - Health Devices Corporation (085927861)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!